Home » Archive

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

News, Syndication »

Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race

Posted by sandiegobiotech June 9th, 2014 .
No Comments

Akebia Therapeutics and its investors had hit a crossroads familiar to many startup biotechs last year. Its lead drug, AKB-6548, a pill for the anemia people get when their kidneys are failing, had…

[[Click headline to continue reading.]]

More...

News, Syndication »

Pfenex Inc. Aims for $74.8M IPO

Posted by sandiegobiotech June 8th, 2014 .
No Comments

Pfenex Inc., a spinoff of Dow Chemical Co., is the latest San Diego biotech to file for an initial public offering, looking to raise $74.8 million to fund its development of biosimilars.

More...

News, Syndication »

Pfenex Inc. Plans $74.8 M illion IPO

Posted by sandiegobiotech June 6th, 2014 .
No Comments

Pfenex Inc., a spinoff of Dow Chemical Co., is the latest San Diego biotech to file for an initial public offering, looking to raise $74.8 million to fund its development of biosimilars.

More...

News, Syndication »

New President, CFO at Celladon Says Co. Ripe to Expand Staff

Posted by sandiegobiotech June 6th, 2014 .
No Comments

I chatted recently with Paul Cleveland, a veteran biotech finance guy who has recently been brought on as president and chief financial officer for the newly public gene therapy company Celladon Corp. Cleveland most recently was CFO of Aragon Pharmaceuticals Inc., a San Diego drugmaker sold to Johnson & Johnson last August for $1 billion.

More...

News, Syndication »

Legislation Aims to Foster Investment in Biotech

Posted by sandiegobiotech June 6th, 2014 .
No Comments

Biotech companies across California and the nation are facing critical issues raising capital. An extraordinary amount of time and money goes into uncovering the next scientific breakthrough; it is estimated that developing a single therapeutic can cos…

More...

News, Syndication »

Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat

Posted by sandiegobiotech June 6th, 2014 .
No Comments

As often happens, industry news from the annual American Society of Clinical Oncology (ASCO) meeting, which ended Wednesday in Chicago, was dominated this year by Big Pharma. It’s not…

[[Click headline to continue reading.]]

More...

News, Syndication »

Sanford-Burnham grad students explore “The Bigger Picture”

Posted by sandiegobiotech June 6th, 2014 .
No Comments

Guest post by Sanford-Burnham graduate student, Matthew Tierney. This past May 21st through the 23rd, students and faculty of the Sanford-Burnham Graduate School of Biomedical Sciences met in Temecula, Calif., for their 5th annual program retreat. The meeting featured Drs. Sarah Hymowitz of Genentech and Paul Rejto of Pfizer as keynote speakers and included three

Read More

More...

News, Syndication »

West Coast Biotech Roundup: NanoString, Sequenom/Agena, CIRM, & More

Posted by sandiegobiotech June 6th, 2014 .
No Comments

In the life sciences, much of the attention was focused in the past week on the American Society of Clinical Oncology conference in Chicago. We’ll have a separate roundup of that news, starring…

[[Click headline to continue reading.]]

More...

News, Syndication »

San Diego biotech Pfenex files for IPO

Posted by sandiegobiotech June 5th, 2014 .
No Comments

Dow Chemical spinoff seeks to raise nearly $75 million.

More...

News, Syndication »

Venter Institute gets $25 million grant

Posted by sandiegobiotech June 5th, 2014 .
No Comments

The NIH grant goes to a new Genome Center for Infectious Diseases at the institute.

More...